News

John McCafferty: The antibody pioneer

27 May 2026

Newly elected both as a Fellow of the Academy of Medical Sciences and Fellow of the Royal Society, John McCafferty has spent more than 3 decades transforming antibodies from natural defenders into medicines that have improved millions of lives.

John McCafferty and James Nathan named as Fellows of 2026 Academy of Medical Sciences

21 May 2026

Professor John McCafferty and James Nathan have been recognised for their outstanding contributions to advancing medical science, each responsible for pioneering discovery research and translating innovation into tangible benefits for patients and the wider public. They join an esteemed Fellowship of over 1,500 researchers...

CITIID Research Highlight: David Jayne

14 May 2026

Our work aims to improve outcomes for patients with multi-system autoimmune disorders, particularly vasculitis, lupus and related conditions.

CITIID Research Highlight: Lalita Ramakrishnan

24 March 2026

Tuberculosis (TB) is an ancient infectious disease caused by bacteria, and it is by far the greatest infectious killer of humanity.

New vulnerability identified in common kidney cancer could open door to new treatments

17 March 2026

Published now in Nature Communications, the study led by James Bertlin, a CRUK-funded MBPhD student, and Professor James Nathan (CITIID) has uncovered a new target in the most common form of kidney cancer which offers a dual therapeutic benefit: selectively killing cancer cells while simultaneously activating the immune...

Professor Yorgo Modis leads collaborative project on MORC2-related disorder

24 February 2026

Professor Yorgo Modis (Department of Medicine, University of Cambridge) is leading a research project with MORCure , a patient-led global charity that leads research, innovation and best practice for individuals with MORC2-related disorder (M2RD), to generate new insights into how genetically inherited variants of the...

CITIID receives Silver LEAF award for sustainability

28 January 2026

CITIID has achieved the Silver LEAF accreditation in recognition of exemplary actions undertaken to improve the sustainability practices as part of the laboratory efficiency assessment framework (LEAF). certificate_silver_2026-01-12_11_27_14_1_page-0001.jpg Building on last year's Bronze LEAF award, the CITIID...

Hidden mpox exposure detected in healthy Nigerian adults, revealing under-recognised transmission

20 January 2026

In a study published today in Nature Communications , Dr Adam Abdullahi, Professor Ravindra Gupta and colleagues show that exposure to the mpox virus can occur without recognised illness, and that residual immunity from historic smallpox vaccination continues to shape how the virus spreads in human populations.

Bird flu viruses are resistant to fever, making them a major threat to humans

28 November 2025

In a study published today in Science, Professor Sam Wilson and colleagues identified a gene that plays an important role in setting the temperature sensitivity of a virus. In the deadly pandemics of 1957 and 1968, this gene transferred into human flu viruses, and the resulting virus thrived.

Advancing typhoid vaccine in Africa

14 November 2025

Cambridge, Seoul and Ghana are working together to bring life-saving solutions across the continent to communities at risk.

John McCafferty: The antibody pioneer

John McCafferty and James Nathan named as Fellows of 2026 Academy of Medical Sciences

CITIID Research Highlight: David Jayne

CITIID Research Highlight: Lalita Ramakrishnan

New vulnerability identified in common kidney cancer could open door to new treatments

Professor Yorgo Modis leads collaborative project on MORC2-related disorder

CITIID receives Silver LEAF award for sustainability

Hidden mpox exposure detected in healthy Nigerian adults, revealing under-recognised transmission

Bird flu viruses are resistant to fever, making them a major threat to humans

Advancing typhoid vaccine in Africa

Contact us

How we use information

Connect with us

as_rgb_silver-award-185.png

Study at Cambridge

About the University

Research at Cambridge